Epic Pharma Llc - Net Worth and Insider Trading

Epic Pharma Llc Net Worth

The estimated net worth of Epic Pharma Llc is at least $12 Million dollars as of 2024-05-29. Epic Pharma Llc is the 10% Owner of Elite Pharmaceuticals Inc and owns about 67,669,232 shares of Elite Pharmaceuticals Inc (ELTP) stock worth over $12 Million. Details can be seen in Epic Pharma Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Epic Pharma Llc has not made any transactions after 2014-03-11 and currently still holds the listed stock(s).

Transaction Summary of Epic Pharma Llc

Epic Pharma Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Epic Pharma Llc owns 1 companies in total, including Elite Pharmaceuticals Inc (ELTP) .

Click here to see the complete history of Epic Pharma Llc’s form 4 insider trades.

Insider Ownership Summary of Epic Pharma Llc

Ticker	Comapny	Transaction Date	Type of Owner
ELTP	Elite Pharmaceuticals Inc	2014-03-11	10 percent owner

Epic Pharma Llc Latest Holdings Summary

Epic Pharma Llc currently owns a total of 1 stock. Epic Pharma Llc owns 67,669,232 shares of Elite Pharmaceuticals Inc (ELTP) as of March 11, 2014, with a value of $12 Million.

Latest Holdings of Epic Pharma Llc

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
ELTP	Elite Pharmaceuticals Inc	2014-03-11	67,669,232	0.18	12,451,139

Holding Weightings of Epic Pharma Llc

Epic Pharma Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Epic Pharma Llc has made a total of 0 transactions in Elite Pharmaceuticals Inc (ELTP) over the past 5 years. The most-recent trade in Elite Pharmaceuticals Inc is the sale of 239,367 shares on March 11, 2014, which brought Epic Pharma Llc around $143,620.

Insider Trading History of Epic Pharma Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Epic Pharma Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Epic Pharma Llc Ownership Network

Ownership Network List of Epic Pharma Llc

No Data

Ownership Network Relation of Epic Pharma Llc

Epic Pharma Llc Owned Company Details

What does Elite Pharmaceuticals Inc do?

Who are the key executives at Elite Pharmaceuticals Inc?

Epic Pharma Llc is the 10 percent owner of Elite Pharmaceuticals Inc. Other key executives at Elite Pharmaceuticals Inc include CFO & Secretary & Treasurer Mark N Pellegrino , Chief Commercial Officer Kirko Kirkov , and CFO & Secretary & Treasurer Chen Robert C J .

Elite Pharmaceuticals Inc (ELTP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Elite Pharmaceuticals Inc (ELTP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Elite Pharmaceuticals Inc (ELTP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Elite Pharmaceuticals Inc (ELTP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Elite Pharmaceuticals Inc Insider Transactions

No Available Data

Epic Pharma Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Epic Pharma Llc. You might contact Epic Pharma Llc via mailing address: 227-15 North Conduit Ave, Laurelton Ny 11413-3134.

Discussions on Epic Pharma Llc

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.